Homelessness — Homeless People in French-speaking Switzerland and Integrative Medicine: A Pilot Intervention in Music Therapy
Citation(s)
Baptista, I and E. Marilier, Fighting homelessness and housing exclusion in Europe: A study of national policies, E.S.P.N. (ESPN), Editor. 2019: Brussels: European Commission.
Furukawa TA, Kessler RC, Slade T, Andrews G The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well-Being. Psychol Med. 2003 Feb;33(2):357-62. doi: 10.1017/s0033291702006700.
Gaddy MA Implementation of an integrative medicine treatment program at a Veterans Health Administration residential mental health facility. Psychol Serv. 2018 Nov;15(4):503-509. doi: 10.1037/ser0000189. Epub 2017 Oct 12.
Garland EL, Roberts-Lewis A, Tronnier CD, Graves R, Kelley K Mindfulness-Oriented Recovery Enhancement versus CBT for co-occurring substance dependence, traumatic stress, and psychiatric disorders: Proximal outcomes from a pragmatic randomized trial. Behav Res Ther. 2016 Feb;77:7-16. doi: 10.1016/j.brat.2015.11.012. Epub 2015 Nov 27. Erratum In: Behav Res Ther. 2018 Jan;100:78.
Maddock, A , D. Hevey, and K. Eidenmuller, Mindfulness training as a clinical intervention with homeless adults: A pilot study. International Journal of Mental Health Addiction, 2017. 15: p. 529-544.
Skevington SM, Lotfy M, O'Connell KA; WHOQOL Group The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004 Mar;13(2):299-310. doi: 10.1023/B:QURE.0000018486.91360.00.
Homeless People in French-speaking Switzerland and Integrative Medicine: A Pilot Intervention in Music Therapy
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
